NO921495L - Oligosakkarid og fremgangsmaate for dets fremstilling - Google Patents

Oligosakkarid og fremgangsmaate for dets fremstilling

Info

Publication number
NO921495L
NO921495L NO92921495A NO921495A NO921495L NO 921495 L NO921495 L NO 921495L NO 92921495 A NO92921495 A NO 92921495A NO 921495 A NO921495 A NO 921495A NO 921495 L NO921495 L NO 921495L
Authority
NO
Norway
Prior art keywords
oligosaccarid
procedure
preparation
oligosaccharide
sulfate
Prior art date
Application number
NO92921495A
Other languages
English (en)
Norwegian (no)
Other versions
NO921495D0 (no
Inventor
Hiroko Habuchi
Sakaru Suzuki
Koji Kimata
Original Assignee
Seikagaku Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Kogyo Co Ltd filed Critical Seikagaku Kogyo Co Ltd
Publication of NO921495D0 publication Critical patent/NO921495D0/no
Publication of NO921495L publication Critical patent/NO921495L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/08—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium
    • C07H5/10—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium to sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO92921495A 1991-04-16 1992-04-15 Oligosakkarid og fremgangsmaate for dets fremstilling NO921495L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11090591 1991-04-16

Publications (2)

Publication Number Publication Date
NO921495D0 NO921495D0 (no) 1992-04-15
NO921495L true NO921495L (no) 1992-10-19

Family

ID=14547637

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92921495A NO921495L (no) 1991-04-16 1992-04-15 Oligosakkarid og fremgangsmaate for dets fremstilling

Country Status (11)

Country Link
US (1) US5849722A (de)
EP (1) EP0509517B1 (de)
KR (1) KR920019810A (de)
AT (1) ATE148470T1 (de)
AU (1) AU656953B2 (de)
CA (1) CA2066305A1 (de)
DE (1) DE69217104T2 (de)
FI (1) FI921689A7 (de)
MX (1) MX9201801A (de)
NO (1) NO921495L (de)
ZA (1) ZA922830B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
GB9206291D0 (en) * 1992-03-23 1992-05-06 Cancer Res Campaign Tech Oligosaccharides having growth factor binding affinity
EP0900804A2 (de) * 1993-03-01 1999-03-10 Glycan Pharmaceuticals, Inc. Analoge für spezifische Oligosaccharide-Protein-Wechselwirkungen und ihre Verwendungen
GB9306255D0 (en) * 1993-03-25 1993-05-19 Cancer Res Campaign Tech Heparan sulphate oligosaccharides having hepatocyte growth factor binding affinity
WO1996001278A1 (en) * 1994-07-01 1996-01-18 Seikagaku Corporation Process for producing desulfated polysaccharide, and desulfated heparin
GB9722604D0 (en) * 1997-10-28 1997-12-24 Cancer Res Campaign Tech Heparin-binding growth factor derivatives
WO2002042336A2 (en) * 2000-11-21 2002-05-30 The Texas A & M University System Fgf-affinity chromatography
WO2002076475A2 (en) * 2001-03-23 2002-10-03 Bioparken As Glycosaminoglycan anticoagulants derived from fish
CH696701A5 (de) * 2001-12-18 2007-10-15 Hoffmann La Roche Verfahren zum Testen eines Mittels auf dessen Fähigkeit, die Heparanaseaktivität zu hemmen.
US20060183712A1 (en) * 2005-02-17 2006-08-17 The Texas A&M University System Affinity purified heparin/heparan sulfate for controlling the biological activity of the FGF receptor
AU2013240972A1 (en) 2012-03-30 2014-10-30 Ajinomoto Co., Inc. Culture medium for proliferating stem cell, which contains sulfated compound
MX2015015814A (es) * 2013-05-16 2016-06-02 Agency Science Tech & Res Sulfatos de heparán.
US10471091B2 (en) 2014-11-19 2019-11-12 Agency For Science, Technology And Research Heparan sulphates for use in repair and/or regeneration of skin
WO2016080915A1 (en) 2014-11-19 2016-05-26 Agency For Science, Technology And Research Cosmetic use of heparan sulphate
CN104530262B (zh) * 2015-01-26 2016-08-24 安徽科宝生物工程有限公司 一种从猪肺中提取肝素的生产方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
US4785079A (en) * 1984-11-09 1988-11-15 The Salk Institute For Biological Studies Isolation of fibroblast growth factor
US4916219A (en) * 1985-03-28 1990-04-10 University Of Iowa Research Foundation Oligosaccharide heparin fragments as inhibitors of complement cascade
FR2597484B1 (fr) * 1986-04-17 1988-12-23 Sanofi Sa Glycosaminoglycanes de type heparine ou heparane-sulfate dotes d'une activite sur la division et la differentiation cellulaires, leur preparation et leurs applications therapeutiques.
US4788307A (en) * 1986-04-30 1988-11-29 Choay S.A. Oligosaccharidic fractions devoid or practically devoid of antithrombotic activity
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
US5100668A (en) * 1988-06-14 1992-03-31 Massachusetts Institute Of Technology Controlled release systems containing heparin and growth factors
JPH0240399A (ja) * 1988-07-27 1990-02-09 Takeda Chem Ind Ltd 線維芽細胞増殖因子ムテインの複合体あるいは組成物
US5175147A (en) * 1988-08-19 1992-12-29 Takeda Chemical Industries, Ltd Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract
PT93847A (pt) * 1989-04-24 1990-11-20 Harvard College Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem
US5126323A (en) * 1989-11-16 1992-06-30 Genetics Institute, Inc. Homogeneous purified k-fgf and compositions containing the same

Also Published As

Publication number Publication date
US5849722A (en) 1998-12-15
ATE148470T1 (de) 1997-02-15
KR920019810A (ko) 1992-11-20
DE69217104D1 (de) 1997-03-13
DE69217104T2 (de) 1997-06-05
EP0509517B1 (de) 1997-01-29
FI921689A0 (fi) 1992-04-15
AU1500392A (en) 1993-03-11
EP0509517A2 (de) 1992-10-21
FI921689L (fi) 1992-10-17
ZA922830B (en) 1993-01-27
AU656953B2 (en) 1995-02-23
MX9201801A (es) 1992-10-30
CA2066305A1 (en) 1992-10-17
NO921495D0 (no) 1992-04-15
FI921689A7 (fi) 1992-10-17
EP0509517A3 (en) 1993-09-01

Similar Documents

Publication Publication Date Title
NO921495L (no) Oligosakkarid og fremgangsmaate for dets fremstilling
US5116441B1 (en) Glass repair kit and method of use
ZA892002B (en) Skin improving composition and method
ZA893882B (en) New heparin derivatives and process for their preparation
AU5841090A (en) Sulphated polysaccharides, anticoagulant agent and anticomplementary agent obtained from brown algae fucuses and method of obtaining same
ZA893618B (en) Process for the production of perfluoropolyethers substantially constituted by perfluorooxyethylene and perfluoroxypropylene units
HUT62315A (en) Process for producing agent promoting hepatocyte growth
AU2749288A (en) Use of polysulfated heparins
HUT63765A (en) Process for producing materials inactivating uracyl reductase enzyme and phqrmaceutical compositions comprising such compounds
DE3569075D1 (en) Method and compositions for use in the treatment of fireblight
CS472690A3 (en) Combination preparation with antithrombotic effect
PL290722A1 (en) Method of cleaning windaw glass panels as well as wipper and cleaning agent therefor
BR8904367A (pt) Processo para reducao da quantidade de halocarbonetos em 2,2-dicloro-1,1,1-trifluoretano
GB8910811D0 (en) Finely powdered hyaluronic acid or sodium hyaluronate and process for producing it
EP0303885A3 (en) Hinge
DE3775435D1 (de) Eine 180-grad-oeffnung erlaubendes tuerscharnier.
DE69521074D1 (de) Transglykosylierungsverfahren zur Herstellung eines Kohlenhydrats oder eines Glykokonjugates
GB2249783A (en) Composition for cleaning gas and process for its production
EP0458640A3 (en) Use of ergoline derivatives for the treatment of diseases associated with bone demineralization
EP0078504A3 (en) Transparent panel for curved walls in revolving doors
EP0288382A3 (en) Derivative of d.25, preparation process, use as immunostimulating agent and pharmaceutical compositions containing it
AU5429490A (en) Structure, in particular made of wood and process for its production
CA2038667A1 (en) Process for the preparation of mannosyl teicoplanin derivatives and mannosyl teicoplanin aglycone
GB8913393D0 (en) Curved toughened glass 11
NZ240150A (en) Fermentation medium and its use in the production of ivermectin derivatives